The major objective of this proposal is to design, synthesis and evaluate redox-based chemical delivery systems (CDS) for neurotrophomodulators (NTM), to achieve brain-enhanced delivery of these NTM's for the treatment of the cognitive decline associated with Alzheimer's disease. The CDS to be used is the redox-based dihydrpyridine yields pyridinium ion system which is covalently attached to the active drug. The dihydropyridine moiety enhances lipophilicity and its oxidation in the brain to the charged, quaternary pyridinium ion serves to lock the drug in the brain. The NTM for which brain-directed CDS's would be attached are 4-methylcatechol; catecholamines and catecholamine analogues; the beta-adrenergic agonist, isoproterenol and terbutaline; novel catechol mimics including methylated derivatives of 2-hydroxy-pyridone-1-oxide; and finally estradiol. Each of these NTM-CDS's would be subjected to in vitro evaluation of their physicochemical properties (lipophilicity, oxidative stability and the degree of protein binding) and in vitro rates of oxidation and hydrolysis. Compounds which show appropriate in vitro characteristics would then be evaluated for their in vivo distribution to brain and peripheral tissues. Those NTM-CDS's which exhibit brain- enhanced delivery and sustained release of the active drug would be assessed for their efficacy in stimulating nerve growth factor (NGF) synthesis and release in cortex and hippocampus. Those NTM-CDS which are delivered to and release NTM in the brain and stimulate secretion of NGF would be further evaluated for their efficacy in enhancing plasticity of cholinergic neurons in animal models for cholinergic hypofunction. High affinity choline uptake, choline acetyltransferase activity and acetylcholine synthesis would be evaluated for their efficacy in enhancing memory in tests of passive avoidance and active avoidance. The most promising of the NTM-CDS's would be synthesized in quantities sufficient to conduct animal toxicity tests. Collectively, the studies described should provide a thorough evaluation of the potential use of NTM-CDS in the treatment of the cognitive decline of Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010485-05
Application #
3726701
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Richter, Frank; Koulen, Peter; Kaja, Simon (2016) N-Palmitoylethanolamine Prevents the Run-down of Amplitudes in Cortical Spreading Depression Possibly Implicating Proinflammatory Cytokine Release. Sci Rep 6:23481
Means, John C; Gerdes, Bryan C; Kaja, Simon et al. (2016) Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging. Neurochem Res 41:2278-88
Montgomery, Christa L; Keereetaweep, Jantana; Johnson, Heather M et al. (2016) Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma. Lipids 51:857-66
Kaja, Simon; Payne, Andrew J; Singh, Tulsi et al. (2015) An optimized lactate dehydrogenase release assay for screening of drug candidates in neuroscience. J Pharmacol Toxicol Methods 73:1-6
Sarkar, Saumyendra; Jun, Sujung; Simpkins, James W (2015) Estrogen amelioration of A?-induced defects in mitochondria is mediated by mitochondrial signaling pathway involving ER?, AKAP and Drp1. Brain Res 1616:101-11
Kaja, Simon; Payne, Andrew J; Naumchuk, Yuliya et al. (2015) Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes. Exp Eye Res 138:159-66
Cheli, V T; Santiago González, D A; Spreuer, V et al. (2015) Voltage-gated Ca2+ entry promotes oligodendrocyte progenitor cell maturation and myelination in vitro. Exp Neurol 265:69-83
Kaja, Simon; Sumien, Nathalie; Shah, Vidhi V et al. (2015) Loss of Spatial Memory, Learning, and Motor Function During Normal Aging Is Accompanied by Changes in Brain Presenilin 1 and 2 Expression Levels. Mol Neurobiol 52:545-54
Kaja, S; Payne, A J; Nielsen, E Ø et al. (2015) Differential cerebellar GABAA receptor expression in mice with mutations in CaV2.1 (P/Q-type) calcium channels. Neuroscience 304:198-208
Grillo, Stephanie L; Koulen, Peter (2015) Psychophysical testing in rodent models of glaucomatous optic neuropathy. Exp Eye Res 141:154-63

Showing the most recent 10 out of 233 publications